1. Home
  2. TFIN vs NBTX Comparison

TFIN vs NBTX Comparison

Compare TFIN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Triumph Financial Inc.

TFIN

Triumph Financial Inc.

N/A

Current Price

$62.34

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$21.65

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TFIN
NBTX
Founded
1981
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
TFIN
NBTX
Price
$62.34
$21.65
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
★ $75.00
$54.00
AVG Volume (30 Days)
★ 220.4K
142.9K
Earning Date
10-21-2026
09-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.22
N/A
EPS
★ 0.67
N/A
Revenue
N/A
N/A
Revenue This Year
$8.04
N/A
Revenue Next Year
$10.12
$50.69
P/E Ratio
$93.16
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.00
$14.78
52 Week High
$83.52
$57.14

Technical Indicators

Market Signals
Indicator
TFIN
NBTX
Relative Strength Index (RSI) 33.83 22.09
Support Level $59.64 $19.99
Resistance Level $62.97 $22.48
Average True Range (ATR) 1.60 1.55
MACD 0.47 -0.57
Stochastic Oscillator 31.51 1.52

Price Performance

Historical Comparison
TFIN
NBTX

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: